These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2013850)

  • 41. [Esterase activity of human organotypic cornea construct (HCC) as in vitro model for permeation studies].
    Meyer L; Bednarz J; Müller-Goymann CC; Reichl S
    Ophthalmologe; 2005 Oct; 102(10):971-80. PubMed ID: 15785910
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of oleic acid on the corneal permeability of compounds and evaluation of its ocular irritation of rabbit eyes.
    Gao XC; Qi HP; Bai JH; Huang L; Cui H
    Curr Eye Res; 2014 Dec; 39(12):1161-8. PubMed ID: 24749683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exponential Decay Metrics of Topical Tetracaine Hydrochloride Administration Describe Corneal Anesthesia Properties Mechanistically.
    Ethington J; Goldmeier D; Gaynes BI
    Cornea; 2017 Mar; 36(3):363-366. PubMed ID: 28060026
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thermosensitive in situ nanogel as ophthalmic delivery system of curcumin: development, characterization, in vitro permeation and in vivo pharmacokinetic studies.
    Liu R; Sun L; Fang S; Wang S; Chen J; Xiao X; Liu C
    Pharm Dev Technol; 2016 Aug; 21(5):576-82. PubMed ID: 26024239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of various concentrations of terpene-4-ol enhancer and carbopol-934 mucoadhesive upon the in vitro ocular transport and the in vivo intraocular pressure lowering effects of dorzolamide ophthalmic formulations using albino rabbits.
    Afouna MI; Khedr A; Abdel-Naim AB; Al-Marzoqi A
    J Pharm Sci; 2010 Jan; 99(1):119-27. PubMed ID: 19530071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug release profiles of ophthalmic formulations. 1. Instrumentation.
    Stevens LE; Missel PJ; Lang JC
    Anal Chem; 1992 Apr; 64(7):715-23. PubMed ID: 1524221
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overcoming the Anatomical and Physiological Barriers in Topical Eye Surface Medication Using a Peptide-Decorated Polymeric Micelle.
    Lin S; Ge C; Wang D; Xie Q; Wu B; Wang J; Nan K; Zheng Q; Chen W
    ACS Appl Mater Interfaces; 2019 Oct; 11(43):39603-39612. PubMed ID: 31580053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ocular surface distribution and pharmacokinetics of a novel ophthalmic 1% azithromycin formulation.
    Akpek EK; Vittitow J; Verhoeven RS; Brubaker K; Amar T; Powell KD; Boyer JL; Crean C
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):433-9. PubMed ID: 19857105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Soluble gentamicin ophthalmic inserts as a drug delivery system.
    Bloomfield SE; Miyata T; Dunn MW; Bueser N; Stenzel KH; Rubin AL
    Arch Ophthalmol; 1978 May; 96(5):885-7. PubMed ID: 655927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New directions in the optimization of ocular drug delivery.
    Lee VH
    J Ocul Pharmacol; 1990; 6(2):157-64. PubMed ID: 2203851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the Ocular Tolerance of Three Tacrolimus Topical Pharmaceutical Preparations by Bovine Corneal Opacity and Permeability Test.
    Pastor-Clerigues A; Serrano A; Milara J; Marti-Bonmati E; Lopez-Perez FJ; Garcia-Montanes S; Sanfeliu J; Saval-Victoria AC; Cortijo J
    Curr Eye Res; 2016 Jul; 41(7):890-6. PubMed ID: 26554729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [New systems of drug administration through a topical ocular administration approach].
    Herrero Vanrell R
    Arch Soc Esp Oftalmol; 2001 Mar; 76(3):143-4. PubMed ID: 11283777
    [No Abstract]   [Full Text] [Related]  

  • 53. Gelucire44/14 as a novel absorption enhancer for drugs with different hydrophilicities: in vitro and in vivo improvement on transcorneal permeation.
    Liu R; Liu Z; Zhang C; Zhang B
    J Pharm Sci; 2011 Aug; 100(8):3186-3195. PubMed ID: 21416467
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ocular drug bioavailability from topically applied liposomes.
    Lee VH; Urrea PT; Smith RE; Schanzlin DJ
    Surv Ophthalmol; 1985; 29(5):335-48. PubMed ID: 3992472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhanced topical corticosteroids delivery to the eye: A trade-off in strategy choice.
    Shen L; Fang G; Tang B; Zhu Q
    J Control Release; 2021 Nov; 339():91-113. PubMed ID: 34560157
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell culture models of the human cornea - a comparative evaluation of their usefulness to determine ocular drug absorption in-vitro.
    Reichl S
    J Pharm Pharmacol; 2008 Mar; 60(3):299-307. PubMed ID: 18284809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Solid lipid nanoparticles for ocular drug delivery.
    Seyfoddin A; Shaw J; Al-Kassas R
    Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Corneal cell culture models: a tool to study corneal drug absorption.
    Dey S
    Expert Opin Drug Metab Toxicol; 2011 May; 7(5):529-32. PubMed ID: 21500964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improved ocular bioavailability of indomethacin by novel ocular drug carriers.
    Calvo P; Alonso MJ; Vila-Jato JL; Robinson JR
    J Pharm Pharmacol; 1996 Nov; 48(11):1147-52. PubMed ID: 8961163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Colloidal nanosystems with mucoadhesive properties designed for ocular topical delivery.
    Silva B; São Braz B; Delgado E; Gonçalves L
    Int J Pharm; 2021 Sep; 606():120873. PubMed ID: 34246741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.